EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 24-Jun-2026 05:16 ET (24-Jun-2026 09:16 GMT/UTC)

Blood test shows promise for detecting testicular cancer when standard markers miss

Mayo Clinic
Peer-Reviewed Publication

Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study published in Nature Communications.

Journal: Nature Communications

Age, sex, and cancer type influence risk of subsequent cancers among survivors

PLOS
Peer-Reviewed Publication

Risk of developing a subsequent primary cancer varied significantly by age at initial diagnosis, sex, and type of first cancer, according to a study by Oxana Palesh and Susan Hong and colleagues at Virginia Commonwealth University, U.S., published April 28^th in the open-access journal PLOS Medicine.

Journal: PLOS Medicine

New ultrasound technique revolutionizes microvascular flow imaging

BMEF (BME Frontiers)
Peer-Reviewed Publication

This study aims to develop a contrast-free, high-sensitivity ultrasound method, denoted as Radon transform-based flow measurement (R-Flow), for in vivo mapping of microvascular flow vectors and for establishing R-Flow-derived vector-field metrics to noninvasively quantify microcirculatory patterns in liver cirrhosis.

Journal: BME Frontiers
Funder: This project was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.

Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of Medicine found that setidegrasib, an investigational targeted therapy drug designed to eliminate a key cancer-driving protein called KRAS G12D, shows encouraging early activity in patients with advanced lung and pancreatic cancers.

New method reveals cellular makeup of environments that favor metastatic cancer growth

Baylor College of Medicine
Peer-Reviewed Publication

Researchers at Baylor College of Medicine and collaborating institutions developed a method that reveals the cellular makeup of tissues that support metastatic cancer growth, which is the primary cause of death for most patients with solid tumors. The method not only revealed cellular features shared by metastatic niches of multiple cancer models but also uncovered an unexpected driver of immune suppression in bone metastasis.

Journal: Cell

AI-assisted optical imaging could ease a major bottleneck in breast cancer surgery

China Anti-Cancer Association
Peer-Reviewed Publication

For many patients with breast cancer, deciding whether cancer has spread to nearby lymph nodes still depends on labor-intensive pathology workflows that require tissue cutting, staining, and expert interpretation.

Journal: Cancer Biology & Medicine

CDI scientists identify key dynamic to boost cancer treatments while limiting stem cell transplant rejection

Hackensack Meridian Health
Peer-Reviewed Publication

A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell transplantation, according to the latest findings

Journal: Cellular and Molecular Immunology

Zinc-Redox crosstalk: a new key to cellular protein quality control

Kyushu University
Peer-Reviewed Publication

Researchers revealed how zinc levels control the endoplasmic reticulum (ER), the cell’s primary protein factory, and how it fundamentally regulates cellular proteostasis. Using fluorescent probes, they found that the transporter ZIP7 keeps zinc levels in the ER low. When ZIP7 is disrupted, zinc level surges, inhibiting the enzyme Ero1 and disrupting the cell’s redox balance. This prevents proteins from folding correctly, leading to an array of pathologies including cancer.

Journal: Nature Communications
Funder: Japan Agency for Medical Research and Development, Japan Science and Technology Agency, Japan Society for the Promotion of Science, Takeda Science Foundation, Asahi Glass Foundation, Japan Agency for Medical Research and Development, Japan Science and Technology Agency, Japan Society for the Promotion of Science, Takeda Science Foundation, Asahi Glass Foundation

The benefits of prostate cancer screening outweigh the harms, according to new patient guidelines from NCCN

National Comprehensive Cancer Network
Business Announcement

Free new patient guide from NCCN shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving lives.

Independent, academic cancer trials are vital to improve patient outcomes worldwide

European Organisation for Research and Treatment of Cancer
Peer-Reviewed Publication

Brussels, Belgium, 27 April 2026 – Independent, academic clinical cancer trials are essential to improving patient outcomes, reducing inequalities in care, and strengthening healthcare systems worldwide, according to a new initiative published in The Lancet Oncology.

Journal: The Lancet Oncology

64
65
66
67
68